VX15/2503

Ligand id: 8932

Name: VX15/2503

No information available.
Summary of Clinical Use
VX15/2503 is in clinical development as a novel therepeutic for various malignancies (Phase I; NCT01313065 completed) and neurodegenerative disorders, including multiple sclerosis (Phase I; NCT01764737 completed) and Huntington's disease (Phase II; NCT02481674).